Superparamagnetic particles targeting rheumatoid arthritis part as well as preparation method and application of particles
A superparamagnetic and rheumatoid technology, applied in preparations for in vivo tests, pharmaceutical formulations, MRI/MRI contrast agents, etc., can solve the problem of poor specificity of Gd-based contrast agents and the ability of joint-targeted imaging Insufficient and other problems, to achieve the effect of improving imaging ability and signal-to-noise ratio, and improving targeting ability
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0067] (1) Activation of folic acid: Dissolve 0.45g of folic acid and 0.21g of DCC in 10.6mL of anhydrous DMSO, and react for 6 hours in the dark;
[0068] (2) Preparation of superparamagnetic particle suspension: take 90 mg of superparamagnetic particles, disperse them in 9 mL of anhydrous DMSO, and keep the final concentration at 1 mg / mL;
[0069] (3) Add the suspension prepared in step (2) to the solution obtained in step (1), and add 12.9 mg of DMAP, and react for 6 hours at room temperature;
[0070] (4) Separation: After the reaction, centrifuge at 5000 rpm / min for 30 min to obtain the product and redisperse it in PBS to obtain the desired contrast agent.
[0071] Wherein (2) the preparation method of the superparamagnetic particle is as follows: the iron acetylacetonate (Fe(acca) 3 ) and 1 g of PEG550-b-PAA1000 were dissolved in triethylene glycol, and the solution was stirred under the protection of an inert gas while heating to 160°C and refluxed, then heating soluti...
Embodiment 2
[0073] (1) Activation of folic acid: Dissolve 4.5g of folic acid and 2.1g of DCC in 10.6mL of anhydrous DMSO, and react for 6 hours in the dark;
[0074] (2) Preparation of superparamagnetic particle suspension: take 900 mg of superparamagnetic particles, disperse them in 9 mL of anhydrous DMSO, and keep the final concentration at 10 mg / mL;
[0075] (3) Add the suspension prepared in step (2) to the solution obtained in step (1), and add 129 mg of DMAP, and react for 6 hours at room temperature;
[0076] (4) Separation: After the reaction, centrifuge at 5000 rpm / min for 30 min to obtain the product and redisperse it in PBS to obtain the desired contrast agent.
[0077] Wherein (2) the preparation method of the superparamagnetic particle is as follows: the iron acetylacetonate (Fe(acca) 3 ) and 1 g of PEG550-b-PAA1000 were dissolved in triethylene glycol, and the solution was stirred under the protection of an inert gas while heating to 160°C and refluxed, then heating solutio...
Embodiment 3
[0079] (1) Activation of folic acid: Dissolve 4.5g of folic acid and 2.1g of DCC in 10.6mL of anhydrous DMSO, and react for 18 hours in the dark;
[0080] (2) Preparation of superparamagnetic particle suspension: take 900 mg of superparamagnetic particles, disperse them in 9 mL of anhydrous DMSO, and keep the final concentration at 10 mg / mL;
[0081] (3) Add the suspension prepared in step (2) to the solution obtained in step (1), and add 129 mg of DMAP, and react for 18 hours at room temperature;
[0082] (4) Separation: After the reaction, centrifuge at 5000 rpm / min for 30 min to obtain the product and redisperse it in PBS to obtain the desired contrast agent.
[0083] Wherein (2) the preparation method of the superparamagnetic particle is as follows: the iron acetylacetonate (Fe(acca) 3 ) and 1 g of PEG550-b-PAA1000 were dissolved in triethylene glycol, and the solution was stirred under the protection of an inert gas while heating to 160°C and refluxed, then heating solut...
PUM
| Property | Measurement | Unit |
|---|---|---|
| Particle size | aaaaa | aaaaa |
| Particle size | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More 